Universitair Medisch Centrum Utrecht
Universitair Medisch Centrum Utrecht is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
Sponsor Argenx
- Start (EU)
- Latest update
- Estimated end
Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)
Sponsor University Medical Center Hamburg-Eppendorf
- Start (EU)
- Latest update
- Estimated end
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 / 2 Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Single Ascending Doses of TRCN-1023 Administered by Intrathecal Injections to Adult People Living with Amyotrophic Lateral Sclerosis
Sponsor Trace Neuroscience Inc.
- Start (EU)
- Latest update
- Estimated end
ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell lymphoma: a phase III national multicenter prospective randomized open-label trial
Sponsor Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon)
- Start (EU)
- Latest update
- Estimated end
- Not reported
Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV International immunisation adaptive platform trial
Sponsor Fondazione Penta Ets
- Start (EU)
- Latest update
- Estimated end
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
Sponsor Argenx
- Start (EU)
- Latest update
- Estimated end
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia
Sponsor Universitair Medisch Centrum Utrecht
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 2 study of trifluridine/tipiracil in patients with ER-positive, HER2-negative advanced breast cancer that previously received chemotherapy (BOOG 2019-01 TIBET study)
Sponsor BOOG Study Center B.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
Sponsor Argenx
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Universitair Medisch Centrum Utrecht?
The 2026-10-09 snapshot links Universitair Medisch Centrum Utrecht to 9 distinct CTIS trials. Recorded services include Laboratory services, Medical expertise, Medicinal product management, Biobanking, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Universitair Medisch Centrum Utrecht?
The most frequently recorded therapeutic areas are Neurology, Cardiology, Haematological Malignancies, Immunology. Recorded phases include Phase 3, Phase 1, Phase 2, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Universitair Medisch Centrum Utrecht conducted?
The linked trials record locations in 24 countries, including Netherlands, Germany, Spain, Italy, Belgium. These are trial locations, not confirmed office locations or countries where Universitair Medisch Centrum Utrecht delivered services.
What can this page tell me about Universitair Medisch Centrum Utrecht's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Universitair Medisch Centrum Utrecht. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Universitair Medisch Centrum Utrecht